scholarly journals Long‐term relapse rates after cognitive behaviour therapy for anxiety and depressive disorders among older adults: A follow‐up study during COVID‐19

2021 ◽  
Author(s):  
Carly J. Johnco ◽  
Jessamine T. H. Chen ◽  
Courtney Muir ◽  
Paul Strutt ◽  
Piers Dawes ◽  
...  
Keyword(s):  
Older Adults ◽  
Cognitive Behaviour Therapy ◽  
Depressive Disorders ◽  
Behaviour Therapy ◽  
Follow Up Study ◽  
Cognitive Behaviour ◽  
Relapse Rates

Fluoxetine and Fluvoxamine Combined with Individual Cognitive-Behaviour Therapy in Binge Eating Disorder: A One-Year Follow-Up Study

2001 ◽  
Vol 70 (6) ◽  
pp. 298-306 ◽  
Author(s):  
Valdo Ricca ◽  
Edoardo Mannucci ◽  
Barbara Mezzani ◽  
Sandra Moretti ◽  
Milena Di Bernardo ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Cognitive Behaviour Therapy ◽  
Behaviour Therapy ◽  
Follow Up Study ◽  
Cognitive Behaviour ◽  
One Year

Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome

2017 ◽  
Vol 97 ◽  
pp. 45-51 ◽  
Author(s):  
Anthonie Janse ◽  
Stephanie Nikolaus ◽  
Jan F. Wiborg ◽  
Marianne Heins ◽  
Jos W.M. van der Meer ◽  
...  
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Cognitive Behaviour Therapy ◽  
Chronic Fatigue ◽  
Behaviour Therapy ◽  
Fatigue Syndrome ◽  
Cognitive Behaviour ◽  
Long Term Follow Up

scholarly journals Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up

2007 ◽  
Vol 97 (5) ◽  
pp. 612-618 ◽  
Author(s):  
M F M Gielissen ◽  
C A H H V M Verhagen ◽  
G Bleijenberg
Keyword(s):  
Cancer Survivors ◽  
Cognitive Behaviour Therapy ◽  
Behaviour Therapy ◽  
Cognitive Behaviour ◽  
Long Term Follow Up

scholarly journals A systematic review of treatment for patients with burning mouth syndrome

Cephalalgia ◽  
2021 ◽  
pp. 033310242110361
Author(s):  
Huann Lan Tan ◽  
Jared G Smith ◽  
Jan Hoffmann ◽  
Tara Renton
Keyword(s):  
Pain Score ◽  
Lipoic Acid ◽  
Cognitive Behaviour Therapy ◽  
Burning Mouth Syndrome ◽  
Alpha Lipoic Acid ◽  
Behaviour Therapy ◽  
Cognitive Behaviour ◽  
Burning Mouth

Background Burning mouth syndrome is a chronic idiopathic intractable intraoral dysaesthesia that remains a challenge to clinicians due to its poorly understood pathogenesis and inconsistent response to various treatments. Aim This review aimed to study the short- (≤3 months) and long-term (>3 months) effectiveness and sustainable benefit of different burning mouth syndrome treatment strategies and the associated side effects. Materials and methods Randomised controlled trials of burning mouth syndrome treatment compared with placebo or other interventions with a minimum follow up of 2 months were searched from the PubMed, Embase and Cochrane database (published to July 2020). Results Twenty-two studies were selected based on the inclusion and exclusion criteria and analysed. Nine categories of burning mouth syndrome treatment were identified: Anticonvulsant and antidepressant agents, phytomedicine and alpha lipoic acid supplements, low-level laser therapy, saliva substitute, transcranial magnetic stimulation, and cognitive behaviour therapy. Cognitive behaviour therapy, topical capsaicin and clonazepam, and laser therapy demonstrated favourable outcome in both short- and long-term assessment. Phytomedicines reported a short-term benefit in pain score reduction. The pooled effect of alpha lipoic acid (ALA) pain score improvement was low, but its positive effects increased in long term assessment. Conclusion A more significant volume in terms of sample size, multi-centres, and multi-arm comparison of therapeutic agents with placebo and longitudinal follow-up studies is recommended to establish a standardised burning mouth syndrome treatment protocol. Further studies are required to assess the analgesic benefits of topical clonazepam and capsaicin, alternative medicines with neurodegenerative prevention capability and psychology support in treating burning mouth syndrome and reducing systemic adverse drug reactions. Registration International Prospective Register of Systematic Reviews (PROSPERO): Protocol ID - CRD42020160892.

Sign in / Sign up

Export Citation Format

Share Document